LEARNING OBJECTIVES

• Identify novel targeted and immunologic approaches to therapy for various cancers

• Integrate recent findings on healthcare disparities into optimal therapy selection for individual patients with cancer

• Identify optimal therapies for patients and managing and mitigating side effects

• Describe findings from recent clinical trials evaluating immunotherapies

• Identify strategies to prevent and manage the treatment related adverse events of targeted therapies and immunotherapies to improve tolerability and maintain quality of life

• Foster discussions on equitable and equal access and delivery of care for disparate populations, including discussing research and drug and diagnostic pipeline development that include underserved and underrepresented patients

ACCREDITATION